Rodney Smith
Urology · Gastonia, NCNPI 1295787174
Payments from drug & device makers
Across 79 payments — averaging $42.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Astellas Pharma US Inc$544
- Procept Biorobotics Corporation$240
- Medtronic$240
- Boston Scientific$161
- Clarus Therapeutics Inc.$115
- plus $720 from 19 others
What the payments were for
- Travel & lodging$1,05931%
- Food & beverage$2,17264%
- Education$1404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 11 | $1,352 |
| Astellas Pharma US Inc | 20 | $544 |
| Procept Biorobotics Corporation | 1 | $240 |
| Medtronic | 6 | $240 |
| Boston Scientific | 7 | $161 |
| Clarus Therapeutics Inc. | 1 | $115 |
| Neotract Inc. | 3 | $106 |
| Antares Pharma, Inc. | 4 | $95 |
| Endo Pharmaceuticals Inc. | 5 | $83 |
| AbbVie | 2 | $68 |
| Ferring Pharmaceuticals Inc. | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 1 | $37 |
| Cook Medical LLC | 2 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Dornier Medtech America, Inc | 1 | $28 |
| Amgen | 2 | $27 |
| Blue Earth Diagnostics | 1 | $25 |
| Healthtronics Stone Solutions, LLC | 1 | $23 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Bayer | 1 | $20 |
| Axonics, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| Dentsply IH Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,176
- JATENZO$345
- AquaBeam Robotic System$240
- INTERSTIM$141
- MYRBETRIQ$115
How this compares
$3,372 in reported general payments places this provider in the 50th percentile of 434 urology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 27 | $14,075 |
| GemtesaVibegron | 16 | $8,384 |
| Tamsulosin Hcl | 157 | $1,701 |
| Finasteride | 70 | $947 |
| Testosterone Cypionate | 15 | $464 |
| Oxybutynin Chloride ErOxybutynin Chloride | 39 | $408 |
| Dutasteride | 16 | $243 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $544 | $14,07527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 434 urology providers in North Carolina.
Other urology in Gastonia
- Sravan PanugantiGastonia$177K
- Daniel GeorgeDurham$17.6M
- Robert LippittSmithfield$11.4M
- Thomas PolascikDurham$4.7M
- Judd MoulDurham$4.1M
- John WrennGreensboro$2.9M
- Michael KennellyCharlotte$1.4M
- John KasparRaleigh$1.1M
- Scott MacdiarmidGreensboro$882K
- Glenn PremingerDurham$736K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.